Composition
- Active ingredients
- DACLATASVIR DIHYDROCHLORIDE EQ 60MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DACLATASVIR DIHYDROCHLORIDE EQ 90MG BASE · TabletNDA206843-003 · Discontinued
- DACLATASVIR DIHYDROCHLORIDE EQ 30MG BASE · TabletNDA206843-001 · Discontinued
- DACLATASVIR DIHYDROCHLORIDE EQ 60MG BASE · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206843.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Daklinza
- Active substance
- daclatasvir dihydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Bristol-Myers Squibb
- Status
- Discontinued
- FDA approval
- 24 Jul 2015
- Application
- NDA206843-002